PCVX vs MSFT: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Microsoft Corp in 2026
PCVX
Vaxcyte Inc
$60.45
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | PCVX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $9.11B | N/A | PCVX |
| P/E Ratio | N/A | 26.32 | MSFT |
| EPS (TTM) | $N/A | $15.97 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze PCVX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or MSFT a better investment?
Comparing PCVX and MSFT: Vaxcyte Inc has a market cap of $9.11B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and MSFT?
PCVX (Vaxcyte Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for PCVX.
Which company is more profitable: PCVX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for PCVX.
Which is the larger company: PCVX or MSFT?
Vaxcyte Inc (PCVX) is larger with a market cap of $9.11B compared to N/A for MSFT.
Should I buy PCVX or MSFT in 2026?
Both PCVX and MSFT have investment merit. PCVX trades at $60.45 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and MSFT stock?
Key differences: Market Cap ($9.11B vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).